Image: Public Affairs Office of the Government of Bashkortostan 

Pharmstandard-UfaVITA JSC and the Government of Bashkortostan plan to implement a 10 bl roubles worth investment project in the region. 

Nail Nizamutdinov, Geberal Director of Pharmstandard-UfaVITA JSC, and Andrey Nazarov, Prime Minister of Bashkortostan, signed the corresponding Memorandum of Understanding on the sidelines of Innoprom 2024 International Exhibition, according to the website of the Government of Bashkortostan.

The investment project includes the construction of a new manufacturing and warehouse facility at the plant. The implementation of the project will result in increasing the production of Phosphogliv, expanding the production of lyophilised forms, widening the range of eye drops manufactured applying BFS technology, and launching the production of suppositories. 

The project implementation will create more than 250 new jobs at the plant.

Earlier, at the 27th St. Petersburg International Economic Forum, Sergei Sobyanin, Moscow Mayor, and Dmitry Zaitsev, JSC Pharmstandard CEO, signed an agreement on cooperation in healthcare development. The agreement provides for the construction of a plant at Alabushevo (Moscow) site to manufacture the essential human plasma-derived medicines.